Yury I Miller Selected Research

Angiotensin II

3/2015

Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yury I Miller Research Topics

Disease

39	Atherosclerosis 01/2020 - 01/2003
24	Inflammation (Inflammations) 01/2021 - 11/2005
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 11/2005
6	Hypercholesterolemia 01/2018 - 04/2009
5	Hyperlipidemias (Hyperlipidemia) 01/2018 - 01/2010
4	Neuroinflammatory Diseases 01/2021 - 01/2018
4	Pain (Aches) 01/2020 - 01/2018
3	Hypertriglyceridemia 01/2018 - 08/2015
2	Rupture 01/2021 - 01/2010
2	Hyperalgesia 01/2021 - 01/2018
2	Neuralgia (Stump Neuralgia) 01/2021 - 01/2020
2	Pathologic Processes 01/2020 - 10/2012
2	Rheumatoid Arthritis 01/2020 - 11/2012
2	Neoplasms (Cancer) 01/2020 - 01/2018
2	Acute Lung Injury 01/2020 - 01/2019
2	Infections 01/2020 - 01/2020
2	Fatty Liver 01/2018 - 01/2014
2	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2017 - 01/2011
2	Hyperlipoproteinemia Type I (Lipoprotein Lipase Deficiency, Familial) 01/2017 - 04/2016
2	Thrombosis (Thrombus) 05/2014 - 10/2013
2	Myocardial Infarction 01/2010 - 04/2009
2	Stroke (Strokes) 01/2010 - 04/2009
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2021
1	Virus Diseases (Viral Diseases) 01/2020
1	COVID-19 01/2020
1	Wounds and Injuries (Trauma) 01/2020
1	Polyneuropathies (Polyneuropathy) 01/2019
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2018
1	Glucose Intolerance 01/2018
1	Weight Gain 01/2018
1	Breast Neoplasms (Breast Cancer) 01/2018
1	Lung Injury 01/2018
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Costello Syndrome 01/2017
1	Pancreatitis 08/2015
1	Xanthomatosis (Xanthoma) 08/2015
1	Autoimmune Diseases (Autoimmune Disease) 11/2012

Drug/Important Bio-Agent (IBA)

22	LipidsIBA 01/2021 - 12/2004
16	oxidized low density lipoproteinIBA 01/2021 - 10/2003
16	Lipoproteins (Lipoprotein)IBA 11/2017 - 09/2005
12	CholesterolIBA 01/2021 - 04/2009
6	LDL Lipoproteins (beta Lipoproteins)IBA 05/2014 - 12/2004
4	EpitopesIBA 01/2019 - 05/2009
4	Apolipoproteins E (ApoE)IBA 01/2018 - 02/2012
4	Phospholipids (Phosphatides)FDA LinkGeneric 01/2017 - 11/2005
4	AntibodiesIBA 10/2013 - 07/2005
3	LipopolysaccharidesIBA 01/2019 - 07/2010
3	1-penicillamyl-Leu(2)- oxytocinIBA 01/2018 - 01/2011
3	Messenger RNA (mRNA)IBA 01/2018 - 01/2014
3	Cholesterol Esters (Cholesteryl Esters)IBA 04/2017 - 01/2011
3	ChemokinesIBA 05/2014 - 09/2009
3	CytokinesIBA 09/2012 - 11/2005
2	Carrier Proteins (Binding Protein)IBA 01/2021 - 10/2020
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 01/2021 - 10/2020
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 10/2013
2	Apolipoprotein C-II (ApoC2)IBA 01/2017 - 08/2015
2	Pattern Recognition ReceptorsIBA 01/2017 - 01/2011
2	Pharmaceutical PreparationsIBA 04/2016 - 01/2012
2	Arachidonate 15-Lipoxygenase (Arachidonate 15 Lipoxygenase)IBA 01/2014 - 09/2009
2	AntigensIBA 10/2013 - 09/2012
2	LigandsIBA 11/2012 - 11/2005
2	C-Reactive ProteinIBA 01/2011 - 10/2003
1	SolutionsIBA 01/2020
1	Opiate AlkaloidsIBA 10/2018
1	Opioid Analgesics (Opioids)IBA 10/2018
1	Cisplatin (Platino)FDA LinkGeneric 01/2018
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2018
1	Single-Chain AntibodiesIBA 01/2018
1	LDL Receptors (LDL Receptor)IBA 01/2018
1	Formaldehyde (Formol)FDA Link 01/2018
1	Surface-Active Agents (Surfactants)IBA 01/2018
1	LDL CholesterolIBA 01/2018
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2018
1	Scavenger Receptors (Scavenger Receptor)IBA 11/2017
1	ApolipoproteinsIBA 11/2017
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2017
1	Fibric Acids (Fibrates)IBA 04/2016
1	ISIS 304801IBA 04/2016
1	Peptides (Polypeptides)IBA 08/2015
1	Lipase (Acid Lipase)FDA Link 08/2015
1	InflammasomesIBA 03/2015
1	locked nucleic acidIBA 03/2015
1	Angiotensin IIIBA 03/2015
1	TOR Serine-Threonine KinasesIBA 05/2014
1	Sirolimus (Rapamycin)FDA Link 05/2014
1	EicosanoidsIBA 01/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2014
1	Triglycerides (Triacylglycerol)IBA 01/2014
1	Omega-6 Fatty Acids (Omega 6 Fatty Acids)IBA 01/2014
1	PlasminogenIBA 10/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2013
1	fostamatinibIBA 11/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2012
1	Biological ProductsIBA 10/2012
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2012

Therapy/Procedure

4	Therapeutics 01/2020 - 01/2011
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2019
1	Spinal Injections 01/2018
1	Injections 01/2018